SK pharmteco
Patrick Manning is currently serving as an R&D PhD Chemist at SK pharmteco since July 2024, focusing on the development and optimization of the synthesis and purification of active pharmaceutical ingredients (APIs) and their precursor compounds, while conducting lab experiments across various scales from milligram to kilogram. Prior to this role, Patrick was a PhD researcher at Trinity College Dublin from November 2019 to June 2024, and holds a Bachelor's degree in Chemistry from the same institution, awarded in 2019.
This person is not in any teams
This person is not in any offices
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.